Oragenics, Inc. (OGEN)
$0.46+0.00%Close
SELLCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 1.25
- P/E (TTM)
- -0.14
- Short % float
- 19.02%
- Days to cover
- 24.9
- SI change
- +4.3%
- 1W
- -6.12%
- 1M
- -8.00%
- vs SPY 1W
- -7.28%
- vs SPY 1M
- -10.99%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on OGEN?
- LOPJLB’s latest quantitative signal on Oragenics, Inc. (OGEN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is OGEN in?
- Oragenics, Inc. (OGEN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Oragenics, Inc. (OGEN) do?
- Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option. Beyond its infectious disease focus, Oragenics also…